Back to Research Home
MRSHMarsh & McLennan Companies, Inc.
Financials · Insurance Brokers
$197.48−0.90%
As of 23 Oct 2026Mkt cap —
Stage 13
WAIT
Fundamentals
50.2/75
Technical
—/15
Independent
—/90
GCAE viewtechnical state requires waiting rather than entering now
Price
- 1M
- +16.2%
- 3M
- +7.7%
- 6M
- +16.1%
- 1Y
- —
Financials & valuation
Cached filing evidence · as of 2026-10-15
Valuation
- P/E
- 23.7xHist median 22.2x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 23.5x
- FCF yield
- 4.3%
Quality
- ROIC
- 14.2%
- Operating margin
- 23.2%
- FCF margin
- 18.5%
- Current ratio
- 1.1x
Growth
- Revenue growth
- +10.3%Latest FY YoY
- Revenue CAGR
- +8.0%
- EPS CAGR
- +8.3%
- FCF CAGR
- +12.6%
Capital
- Share-count trend
- −0.5%3Y annualised
- Net debt
- $18.8B3.5x OCF
Annual trend
- CAGR 2021–2025
- +8.0%
- Latest · 2025
- $27B
- YoY
- +10.3%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
technical state requires waiting rather than entering now
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2027-01-28
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- insufficient-data
- Rotation
- headwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-15
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded